Fluorescence studies of fibroblasts, lymphocytes, and erythrocytes in Huntington's disease
Pettegrew, J.W.; Nicholas, J.S.; Stewart, R.M.
Transactions of the American Neurological Association 104: 61-66
1979
ISSN/ISBN: 0065-9479 PMID: 162257 Document Number: 153764
Document emailed within 1 workday
Related Documents
Nukina, N. 1999: The function of Huntington disease gene product (huntingtin) and the pathomechanism of Huntington disease Nihon Rinsho. Japanese Journal of Clinical Medicine 57(4): 905-911Akiyama, M.; Kyoizumi, S.; Hirai, Y.; Hakoda, M.; Nakamura, N.; Awa, A.A. 1990: Studies on chromosome aberrations and HPRT mutations in lymphocytes and GPA mutation in erythrocytes of atomic bomb survivors Progress in Clinical and Biological Research 340c: 69-80
Perry, T.L.; Hansen, S. 1990: What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies Neurology 40(1): 20-24
Panfilova, I.K. 1972: Fluorescence of erythrocytes in children Pediatriia 51(2): 70-72
Charbonne, F.; Rousseau, P.; Malpuech, G.; Geneix, A. 1980: Tay-Sachs disease: a case report. Interest of ultrastructural studies of cultured skin fibroblasts Archives Francaises de Pediatrie 37(1): 51-53
Sominskiĭ, V.N.; Bluma, R.K.; Kalninia, I.E. 1985: The use of fluorescence probes in the study of the beta-adrenoreceptor function of human erythrocytes Biofizika 30(4): 642-645
Milanino, R.; Frigo, A.; Bambara, L.M.; Marrella, M.; Moretti, U.; Pasqualicchio, M.; Biasi, D.; Gasperini, R.; Mainenti, L.; Velo, G.P. 1993: Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment Clinical and Experimental Rheumatology 11(3): 271-281
Roos, R.A.; Vegter-van der Vlis, M.; Tibben, A.; Skraastad, M.I.; Pearson, P.L. 1990: Procedure and initial results of presymptomatic DNA studies in Huntington's chorea Nederlands Tijdschrift Voor Geneeskunde 134(14): 704-707
Paegelow, I.; Lange, P. 1982: Pharmacological studies on lymphocytes. 1. Effects of 5-hydroxytryptamine, bradykinin, and lymphokines on the migration of lymphocytes in vitro Agents and Actions. Supplements 10: 255-265
Kwak, S. 2002: Huntington disease Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 4): 417-421
Forbes, I.J.; Zalewski, P.D. 1976: A subpopulation of human B lymphocytes that rosette with mouse erythrocytes Clinical and Experimental Immunology 26(1): 99-107
Petersén, A.; Hansson, O.; Brundin, P. 2001: Huntington disease--yet another mad protein? Lakartidningen 98(50): 5756-5758; 5761
Arrojo Romero, M.; Silva, A.F.; Palha, A.P. 2006: Hypochondriasis and Huntington's disease Actas Espanolas de Psiquiatria 34(1): 65-66
Shure, D.; Senior, R.M.; Griffin, G.L.; Deuel, T.F. 1992: PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokines Biochemical and Biophysical Research Communications 186(3): 1510-1514
O'Neill, P.A.; Woodson, D.L.; Mackler, B.F. 1978: EAC rosette-forming lymphocytes in commercial preparations of sheep erythrocytes Journal of Immunology 121(6): 2586-2587
Sanberg, P.R.; Koutouzis, T.K.; Freeman, T.B.; Emerich, D.F.; Bertino, A.M.; Cahill, D.W. 1992: Cell transplantation for Huntington's disease Transplantation Proceedings 24(6): 3015-3016
Caspary, P.; Podoll, K.; Noth, J.; Lange, H.W. 1990: Language disorders in Huntington disease Der Nervenarzt 61(7): 385-389
Coyle, J.T. 1979: An animal model for Huntington's disease Biological Psychiatry 14(2): 251-276
McAtee, O.B. 1979: Huntington's disease: diagnosis and treatment Journal of the Indiana State Medical Association 72(11): 839-841
Schaefer, F.V.; Floyd, M.; Say, B. 1992: Huntington disease: a detective story Journal of the Oklahoma State Medical Association 85(5): 223-226